HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nebih Lolak Selected Research

Sulfaguanidine

4/2021Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nebih Lolak Research Topics

Disease

2Diabetes Mellitus
05/2021 - 04/2021
2Alzheimer Disease (Alzheimer's Disease)
05/2021 - 04/2021
1Metabolic Diseases (Metabolic Disease)
05/2021
1Pigmentation Disorders (Ito Syndrome)
12/2020

Drug/Important Bio-Agent (IBA)

3EnzymesIBA
05/2021 - 12/2020
3ButyrylcholinesteraseIBA
05/2021 - 12/2020
3AcetylcholinesteraseIBA
05/2021 - 12/2020
12-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA
05/2021
1Cholinesterases (Cholinesterase)IBA
05/2021
1GlucosidasesIBA
05/2021
1SulfaguanidineIBA
04/2021
1Glycoside Hydrolases (Endoglycosidases)IBA
04/2021
1Monophenol Monooxygenase (Tyrosinase)IBA
12/2020
1Schiff Bases (Schiff Base)IBA
12/2020